Back to Top

"One of today's leaders in investor relations and shareholder services"

Tag Archives: RXMD

Progressive Care, Inc. (RXMD)

Progressive Care Inc. Reports Largest Six-Month Revenue Period in Company History in Q2 2018 Financial Filing

Progressive Care, Inc. (RXMD)

MIAMI, Aug. 14, 2018 (GLOBE NEWSWIRE) — Progressive Care Inc. (OTCQB: RXMD), a personalized healthcare services and technology company, today announced financial results for the quarter ending June 30, 2018, and provided an overview of recent operational highlights along with updates on the Company’s strategies.

Progressive Care dispensed more than 67,000 prescriptions in Q2 2018, a 21.45% increase over Q2 2017, and 133,000 prescriptions for the six-month period ending June 30, a 23% increase over the same period in 2017. Pharmacy revenue for the six-month period ending June 30, 2018, was approximately $10.3 million, the largest six-month period in the Company’s history and an increase of 3.41%. Progressive Care’s total assets were $3,503,769 as of June 30, 2018, compared to $2,447,865 as of June 30, 2017 — an increase of 43.13%. The Company continues to generate positive cash flow from its operations, with positive operational cash flow of approximately $69,000 for the six-month period ending June 30, 2018.

Progressive Care also reported raising over $1.4 million for 340B charitable organizations during Q2 2018, and $2.7 million total for the six-month period ending June 30, 2018. The Company’s total reported revenue included approximately $125,000 in fees earned on dispensing prescription medications to patients under 340B programs managed by two non-profit healthcare organizations in Florida. The Company expects expanded revenue growth through the signing of two new 340B contracts in July 2018. The contracts with Hope and Help Center of Central Florida and Care 4 U Management will begin on Oct. 1, 2018.

“We are proud to announce another quarter of significant growth compared to last year,” said S. Parikh Mars, CEO of Progressive Care Inc. “During this quarter, we completed our acquisition of Touchpoint Rx, continued developing our healthcare technological offering with the introduction of the PharmCo Smart-Pack Pouch Packaging system and the development of our own proprietary tele-pharmacy software called Tele-PharmCo.”

Mars continued: “Finally, through the launch of our alternative pain management therapies, we were able to begin diversifying Progressive Care’s suite of services and further position ourselves as a preferred online provider of healthcare resources for patients, physicians and providers. We hope that through these efforts, Progressive Care will be able to continue delivering increased value to our shareholders.”  

Progressive Care anticipates that future growth will be driven by continued expansion into new market territories, concentrated efforts toward developing its compliance and adherence services provided to medical providers, and enhancement of technological opportunities that boost loyalty and customer satisfaction. Areas of current development include market penetration of Palm Beach and Martin Counties through the acquisition of Touchpoint Rx, LLC; the development of its Tele-PharmCo platform for its wholly owned subsidiary, PharmCo, LLC; the development and deployment of its online prescription management solution; and implementation of MTM protocols.

SECOND QUARTER 2018 HIGHLIGHTS
During the second quarter of 2018, Progressive Care Inc. achieved the following milestones and significant events:

Reported record-breaking year-over-year sales and growth numbers
In Q2 2018, the Company reported a total of $10.3 million in revenue, the largest single six-month period in its history to date. Progressive Care also experienced increases in prescriptions filled, reporting a 21.45% increase compared to the same quarter in 2017. Progressive Care’s pharmacy services revenue growth is a result of the Company’s expanding breadth of services, manufacturer price increases, new drugs coming to market, new indications for existing drugs, volume growth with current clients, and addition of new customers due to its focus on higher patient engagement and clinical expertise.  

The Company dispensed a total of 66,800 prescriptions in Q2 2018, a 21.45% increase over Q2 2017. Progressive Care’s total assets were $3,503,769 as of June 30, 2018, compared to $2,447,865 as of June 30, 2017 — an increase of 43.13%.

Furthered growth and expansion plans through pharmacy acquisition
The Company executed a definitive agreement to purchase the Touchpoint Rx pharmacy in Palm Beach County. Under this agreement, PharmCo assumed all day-to-day management of the pharmacy, which included assumption of all revenue and expenses. The acquisition will facilitate the Company’s growth plans by decreasing the cost of servicing its delivery radius into Martin County, which includes Jupiter and Stuart, and will decrease costs of expansion and increase prescription dispensing efficiency.

Expansion of robot pharmacy machinery fleet 
The Company purchased and installed a new Automated Pouch Packaging System for its Miami-Dade County PharmCo location. Progressive Care’s wholly-owned subsidiary, PharmCo, LLC, is one of the first in South Florida to offer this new packaging system PharmCo Smart-Pack that allows patients to receive customized dosage pouches according to their daily prescription needs.

Continued development of technology driven healthcare service options
The Company rolled out its online prescription management solution allowing PharmCo patients to visit www.pharmcopharmacy.com and access the company’s prescription management platform, making the prescription request process even easier. The web-based forms are user-friendly and fully integrated for easy processing and quick turn-around on new, transfer and refill prescriptions.

Additionally, the Company started the development of its own proprietary tele-pharmacy software, Tele-PharmCo, to digitally communicate with patients, physicians, pharmacists and caretakers across the world. This state-of-the-art multi-platform technology will be capable of running on kiosk, desktop and mobile devices. The move comes as part of Progressive Care’s overall effort to expand its current kiosk program.

Provided further education on alternative treatments to opioids
The Company launched a new program designed to educate patients and providers on treatment alternatives to opioids available through the company. The campaign is part of the Company’s initiative to spread awareness of available alternative therapies that can improve a person’s quality of life and, in many cases, prevent tragedy caused by opioid abuse and solve the nationwide epidemic.

Maintained steady investor relations activity
The Company actively communicated with its customers and shareholders through various investor announcements.

These efforts included:

  • Acting to alleviate pressure caused by naked short positions in the Company’s stock. The Company contacted several broker/dealers, clearing firms and reached out to FINRA’s Division of Market Regulation about the problem naked shorting is causing in the market for the Company’s securities.
  • Partnering with CMW Media as its public relations agency of record as part of Progressive Care’s overall effort to expand marketing and communications activities for the company and all subsidiaries.
  • Engagement with The Benchmark Company, LLC as a financial advisor as it moves forward with the process of re-registration with the U.S. Securities and Exchange Commission and pursuing a listing on a national securities exchange.

SECOND QUARTER 2018 FINANCIAL RESULTS

Net Revenue: For the six-month period ending June 30, 2018, Progressive Care showed net sales of $10,268,886, as compared to net sales of $9,930,422 for the six-month period that ended June 30, 2017, an increase of 3.41%.

Balance Sheet: Total Assets for the company were $3,503,769 as of June 30, 2018, compared to $2,447,865 as of June 30, 2017, an increase of 43.13%.

Net Cash Provided by Operating Activities: Operating cash flow increased from ($272,769) to $69,444 year-over-year, which is an increase of over 125.45%.

For more information about Progressive Care, please visit the company’s website.

Connect and stay in touch with us on social media:

Progressive Care Inc.
https://www.facebook.com/ProgressiveCareUS/
https://twitter.com/ProgressCareUS

PharmCo, LLC
https://www.facebook.com/pharmcorx/
https://twitter.com/PharmCoRx

About Progressive Care Inc. 
Progressive Care Inc. (OTCQB: RXMD), through its PharmCo, LLC, is a South Florida health services organization and provider of prescription pharmaceuticals, compounded medications, provider of tele-pharmacy services, the sale of anti-retroviral medications, medication therapy management (MTM), the supply of prescription medications to long term care facilities, and health practice risk management.

Cautionary Statement Regarding Forward Looking Statements
Statements contained herein that are not based upon current or historical fact are forward-looking in nature and constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Such forward-looking statements reflect the Company’s expectations about its future operating results, performance and opportunities that involve substantial risks and uncertainties. These statements include but are not limited to statements regarding the intended terms of the offering, closing of the offering and use of any proceeds from the offering. When used herein, the words “anticipate,” “believe,” “estimate,” “upcoming,” “plan,” “target,” “intend” and “expect” and similar expressions, as they relate to Progressive Care Inc., its subsidiaries, or its management, are intended to identify such forward-looking statements. These forward-looking statements are based on information currently available to the Company and are subject to a number of risks, uncertainties, and other factors that could cause the Company’s actual results, performance, prospects, and opportunities to differ materially from those expressed in, or implied by, these forward-looking statements.

Public Relations Contact: 
Tory Patterson, CMW Media 
Tory@cmwmedia.com 
www.cmwmedia.com

Investor Relations Contact: 
Armen Karapetyan, Progressive Care 
Senior Advisor Business Development
Armen@progressivecareus.com
www.progressivecareus.com
www.pharmcopharmacy.com

Posted in Interviews| Tagged |

Progressive Care Announces Pay-Off of Note to Chicago Venture Partners

MIAMI, Aug. 09, 2018 (GLOBE NEWSWIRE) — Progressive Care Inc. (OTCQB: RXMD), a personalized healthcare services and technology company, today announced that it has paid off its convertible note to Chicago Venture Partners through an issuance of common stock.

Progressive Care drew down a tranche against the Chicago Venture note in the amount of $636,304 on February 15, 2018. The issuance of 1,974,279 shares of Progressive Care stock on August 8, 2018 brings the company to a balance of zero and the total number of issued shares to 15,503,604.

The company has been working to pay down its liabilities while continuing to increase revenues and bring increased value to its shareholders.

“We have a long-standing relationship with Chicago Venture Partners and they have played an instrumental role in allowing Progressive Care to move forward with its expansion plans,” said S. Parikh Mars, CEO of Progressive Care. “Being able to pay off this convertible note is an exciting milestone for the company, as we can now shift our entire focus to accelerating our expansion plans.”

Progressive Care recently announced its plans to host a conference call for its investors on Tuesday, Aug. 14, 2018, at 4:30 pm ET to discuss financial results for the second quarter of 2018. The company also plans to provide an update on the company’s recent progress and upcoming milestones.

For more information about Progressive Care, please visit the company’s website.

Connect and stay in touch with us on social media:

Progressive Care Inc.
https://www.facebook.com/ProgressiveCareUS/
https://twitter.com/ProgressCareUS

PharmCo, LLC
https://www.facebook.com/pharmcorx/
https://twitter.com/PharmCoRx

About Progressive Care Inc.
Progressive Care Inc. (OTCQB: RXMD), through its PharmCo, LLC, is a South Florida health services organization and provider of prescription pharmaceuticals, compounded medications, provider of tele-pharmacy services, the sale of anti-retroviral medications, medication therapy management (MTM), the supply of prescription medications to long term care facilities, and health practice risk management.

Cautionary Statement Regarding Forward Looking Statements
Statements contained herein that are not based upon current or historical fact are forward-looking in nature and constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Such forward-looking statements reflect the Company’s expectations about its future operating results, performance and opportunities that involve substantial risks and uncertainties. These statements include but are not limited to statements regarding the intended terms of the offering, closing of the offering and use of any proceeds from the offering. When used herein, the words “anticipate,” “believe,” “estimate,” “upcoming,” “plan,” “target,” “intend” and “expect” and similar expressions, as they relate to Progressive Care Inc., its subsidiaries, or its management, are intended to identify such forward-looking statements. These forward-looking statements are based on information currently available to the Company and are subject to a number of risks, uncertainties, and other factors that could cause the Company’s actual results, performance, prospects, and opportunities to differ materially from those expressed in, or implied by, these forward-looking statements.

Public Relations Contact:
Tory Patterson, CMW Media
Tory@cmwmedia.com
www.cmwmedia.com

Investor Relations Contact:
Armen Karapetyan, Progressive Care
Senior Advisor Business Development
Armen@progressivecareus.com
www.progressivecareus.com
www.pharmcopharmacy.com

Posted in Client News| Tagged |

CORRECTING and REPLACING — Progressive Care to Host Conference Call on Second Quarter 2018 Financial Results and Business Update on Aug. 14

MIAMI, Aug. 07, 2018 (GLOBE NEWSWIRE) — In a release issued under the same headline earlier today by Progressive Care Inc. (OTCQB:RXMD), please note in the third paragraph the question submission deadline should be August 13, 2018, not May 14, 2018 as previously stated. The corrected release follows:

Progressive Care Inc. (OTCQB: RXMD), a personalized healthcare services and technology company, today announced that the company will host a conference call on Tuesday, Aug. 14, 2018, at 4:30 PM ET to discuss financial results for the second quarter of 2018. Progressive Care management will also provide an update on the company’s recent progress and upcoming milestones.

“We have had a lot of exciting updates and news over the last three months,” said S. Parikh Mars, CEO of Progressive Care Inc. “As always, we feel that it is important to continue broadcasting our positive results and keep our investors informed on the company’s developments. We look forward to these quarterly calls and having the opportunity to address specific questions from investors and shareholders.”

Company shareholders, investors and other interested parties will also have the opportunity to submit company-related questions prior to the call to Stuart Smith at SmallCapVoice.Com, Inc. via email: ssmith@smallcapvoice.com. Questions must be submitted by 3:00 PM ET on Monday, August 13, 2018. Prior to the conference call, Smith will compile and share all questions with Progressive Care for final consideration. Questions selected to be included in the conference call will be based on relevance to the shareholder base and appropriateness, considering public disclosure rules.

Interested parties can access the Q2 2018 investor call by using the provided dial-in details below:

Dial-In Number: (857) 232-0157
Access Code: 422095

For those unable to participate in the live conference call, a replay will be made available at https://smallcapvoice.com/blog/rxmd/ shortly after the call has concluded. An archived version of the webcast will also be available at https://progressivecareus.com/investor/.

For more information about Progressive Care, please visit the company’s website.

Connect and stay in touch with us on social media:

Progressive Care Inc.
https://www.facebook.com/ProgressiveCareUS/
https://twitter.com/ProgressCareUS

PharmCo, LLC
https://www.facebook.com/pharmcorx/
https://twitter.com/PharmCoRx

About Progressive Care Inc.
Progressive Care Inc. (OTCQB: RXMD), through its PharmCo, LLC, is a South Florida health services organization and provider of prescription pharmaceuticals, compounded medications, provider of tele-pharmacy services, the sale of anti-retroviral medications, medication therapy management (MTM), the supply of prescription medications to long term care facilities, and health practice risk management.

Cautionary Statement Regarding Forward Looking Statements
Statements contained herein that are not based upon current or historical fact are forward-looking in nature and constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Such forward-looking statements reflect the Company’s expectations about its future operating results, performance and opportunities that involve substantial risks and uncertainties. These statements include but are not limited to statements regarding the intended terms of the offering, closing of the offering and use of any proceeds from the offering. When used herein, the words “anticipate,” “believe,” “estimate,” “upcoming,” “plan,” “target,” “intend” and “expect” and similar expressions, as they relate to Progressive Care Inc., its subsidiaries, or its management, are intended to identify such forward-looking statements. These forward-looking statements are based on information currently available to the Company and are subject to a number of risks, uncertainties, and other factors that could cause the Company’s actual results, performance, prospects, and opportunities to differ materially from those expressed in, or implied by, these forward-looking statements.

Public Relations Contact:
Tory Patterson, CMW Media
Tory@cmwmedia.com
www.cmwmedia.com

Investor Relations Contact:
Armen Karapetyan, Progressive Care
Senior Advisor Business Development
Armen@progressivecareus.com
www.progressivecareus.com
www.pharmcopharmacy.com

Posted in Client News| Tagged |

New Software from Progressive Care Inc. Offers a Major Improvement in Communication and Convenience when Ordering Medications

Two months ago, when Progressive Care Inc. (OTC QB: RXMD), a personalized healthcare services and technology company, announced that the company has started the development of its own proprietary tele-pharmacy software to digitally communicate with patients, physicians, pharmacists and caretakers across the world, the news was met with little fervor. Now, as the rollout of this software that allows a video conference in real time with a pharmacy tech is close at hand, the implications and uses for the software warrant a closer look. The rollout will come in two stages with Progressive Care delivering a state-of-the-art multi-platform technology capable utilizing their innovative kiosks first and then allowing users at home or on the go to use the software.

With Progressive Care’s effort to expand its current kiosk program throughout the state of Florida and into healthcare facilities, retirement communities, workplaces and beyond, the software will save users time and money. That is not where the savings end though. Imagine when employees can visit a kiosk at there place of employment to speak with a pharmacy tech, order their prescription, and have it delivered to their job before their shift is over. In this example the employer also saves. The employee does not have to leave to accomplish any of these time-consuming tasks or drive to pharmacy. Imagine an assisted living complex where tenants no longer need a ride to and from the pharmacy to speak with a pharmacist and fill their prescriptions. The patients and staff can communicate directly via the kiosk without leaving the facility. A convenient kiosk can be placed in the lobby, saving time and money for the tenant, the facility and the pharmacy. This is a streamlined approach that not only saves time and money, but it is safer a alternative as well, reducing trips to the physician or pharmacy. Bottom line, quality of life and free time both improve through increased ease of ordering prescriptions with this proprietary software created by Progressive Care.

“Our success with prescription management has allowed us to begin developing our own proprietary tele-pharmacy software. After configuring a third-party platform in our kiosks, we realized the need to develop a more customized solution for our customers,” said S. Parikh Mars, CEO of Progressive Care Inc. “We believe that with the completion of this new software, along with Progressive Care’s current contingent of pharma-robotic equipment, we will be that much closer to becoming the leader in personalized healthcare services and technology.”

Progressive Care Inc. has seen success because they don’t simply react to the shifting expectations in healthcare – they actively strategize ways to anticipate and exceed consumer expectations. Now, look the second stage of the rollout where now patients at home and on the go can video conference with their pharmacist, provide an image of their insurance card and prescription and have their medications waiting for them when they get home. All of this being accomplished via their smart phone or tablet. What about the single parent at home with a sick child? They can now use their desktop computer to video conference with the with a tech who can communicate with the doctor’s office confirm the meds needed and have them delivered to family at home. Soon Progressive Care Inc. will provide its customers with a digital window allowing them to conveniently fill their prescriptions in the most convenient way to date.

There are still a lot of ways that healthcare needs to change to become truly effective for the everyday citizen, but RXMD is making some truly amazing strides when it comes to challenging the status quo and offering more to their growing base of customers. “We are committed to making medication management as easy as possible for both providers and patients,” said S. Parikh Mars.

To that end the Company is also giving their own website a facelift that accurately depict where the Company is today. So much has changed for RXMD in the past few months and now interested parties will be able to learn more about programs like DischargeRX and the new program designed to educate patients and providers on treatment alternatives to opioids available through the company. More content will be available about the TCGRx Automated Pouch Packaging System and other technologies employed by the company.

About the Author

Stuart Smith is the CEO and Founder of SmallCapVoice.com. SmallCapVoice.com. is a recognized corporate investor relations firm, with clients nationwide, known for its ability to help emerging growth companies build a following among retail and institutional investors. SmallCapVoice.com utilizes its stock newsletter to feature its daily stock picks, audio interviews, as well as its clients’ financial news releases. SmallCapVoice.com also offers individual investors all the tools they need to make informed decisions about the stocks they are interested in. Tools like stock charts, stock alerts, and Company Information Sheets can assist with investing in stocks that are traded on the OTC BB and Pink Sheets. To learn more about SmallCapVoice.com and their services, please visit https://smallcapvoice.com/blog/the-small-cap-daily-small-cap-newsletter/

Posted in Articles| Tagged , |

Progressive Care Earns Coveted LegitScript Certification Verifying PharmCo Pharmacy is a Safe and Credible Online Health Resource

MIAMI, Aug. 01, 2018 (GLOBE NEWSWIRE) — Progressive Care Inc. (OTCQB: RXMD), a personalized healthcare services and technology company, today announced that its subsidiary, PharmCo, LLC, has received certification approval from LegitScript to provide verification that it is operating in compliance with applicable laws and regulation set forth to be a safe and credible online health resource.

The LegitScript verification allows the company to begin marketing and advertising PharmCo products and services online. In addition, Progressive Care will be able to move forward with further efforts on its opioid alternative treatment program launched earlier this year. Through this verification, patients and physicians will have the opportunity to learn more about PharmCo’s alternative pain management therapies and how to best integrate these treatments into a medication regimen.

“Progressive Care continues to look for new ways to expand our market share and network of patients, physicians, and providers. This new certification from LegitScript not only showcases the credibility of the PharmCo Pharmacy, but also enables us to continue sharing our message with a larger audience,” said S. Parikh Mars, CEO of Progressive Care Inc. “We are also excited about the new market opportunities this verification presents and believe this additional level of credibility will have a significant impact on company sales moving forward.”

Progressive Care began the verification process with LegitScript in May 2018 and received final approval on July 31, 2018.

Completion of the LegitScript certification process is one of Progressive Care’s many efforts to expand and educate its network. The company recently launched an opioid alternative treatment campaign in an effort to combat the nationwide opioid epidemic. The company also launched DischargeRx, a new proprietary patient engagement program designed to ensure that hospital patients are receiving the best transitional care while preserving vital hospital resources.

For more information about Progressive Care, please visit the company’s website.

Connect and stay in touch with us on social media:

Progressive Care Inc.
https://www.facebook.com/ProgressiveCareUS/
https://twitter.com/ProgressCareUS

PharmCo, LLC
https://www.facebook.com/pharmcorx/
https://twitter.com/PharmCoRx

About Progressive Care Inc.
Progressive Care Inc. (OTCQB: RXMD), through its PharmCo, LLC, is a South Florida health services organization and provider of prescription pharmaceuticals, compounded medications, provider of tele-pharmacy services, the sale of anti-retroviral medications, medication therapy management (MTM), the supply of prescription medications to long term care facilities, and health practice risk management.

Cautionary Statement Regarding Forward Looking Statements
Statements contained herein that are not based upon current or historical fact are forward-looking in nature and constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Such forward-looking statements reflect the Company’s expectations about its future operating results, performance and opportunities that involve substantial risks and uncertainties. These statements include but are not limited to statements regarding the intended terms of the offering, closing of the offering and use of any proceeds from the offering. When used herein, the words “anticipate,” “believe,” “estimate,” “upcoming,” “plan,” “target,” “intend” and “expect” and similar expressions, as they relate to Progressive Care Inc., its subsidiaries, or its management, are intended to identify such forward-looking statements. These forward-looking statements are based on information currently available to the Company and are subject to a number of risks, uncertainties, and other factors that could cause the Company’s actual results, performance, prospects, and opportunities to differ materially from those expressed in, or implied by, these forward-looking statements.

Public Relations Contact:
Tory Patterson, CMW Media
Tory@cmwmedia.com
www.cmwmedia.com

Investor Relations Contact:
Armen Karapetyan, Progressive Care
Senior Advisor Business Development
Armen@progressivecareus.com
www.progressivecareus.com
www.pharmcopharmacy.com

Posted in Client News| Tagged |

Progressive Care Subsidiary PharmCo Partners with Westchester General Hospital to Implement New DischargeRx Program

MIAMI, July 26, 2018 (GLOBE NEWSWIRE) — Progressive Care Inc. (OTCQB:RXMD), a personalized healthcare services and technology company, today announced a partnership with Westchester General Hospital to implement DischargeRX transitional care program. Westchester General Hospital is the first hospital to begin using Progressive Care’s new proprietary patient engagement program, first launched earlier this month.

After working with patients in the hospital setting, Westchester General Hospital has identified numerous readmission risks stemming from post-discharge/transitional care. Their case workers routinely work with patients to minimize these difficulties but have been dutifully searching for an effective solution to transitional care management. Through Progressive Care’s wholly owned subsidiary PharmCo, LLC, DischargeRX will provide Westchester with much-needed support to prevent unnecessary and costly hospital readmissions. DischargeRX will offer hospital patients and physicians access to a PharmCo representative, who will offer medication-related services throughout the patient’s transitional process.

“Westchester General Hospital is looking to interrupt the standard care model and implement innovative solutions. Patients need a reliable advocate and healthcare service provider who can manage and monitor patient adherence and outcomes outside of the hospital setting,” said Rudy Garcia, CEO of Westchester General Hospital. “We believe that PharmCo’s DischargeRX program is the answer we have been looking for and hope that our patients can now look forward to getting even more value when they choose our hospital.”

The partnership with PharmCo will allow Westchester General Hospital to continue its mission of going above and beyond for the patient. The implementation of the DischargeRX transitional care program will help to solve many of the problems associated with timely medication reconciliations, patient consultation and education, prescription access and adherence, and post-discharge follow-ups. Through direct interaction with the patient, PharmCo will provide medication synchronization, PharmCo SmartPack adherence packaging options, and care coaching to ensure patients understand their treatment, stay on track and follow-up with their physicians.

“Westchester General Hospital has devoted many resources to deliver quality care to its patients and believes that healthcare success involves access and engagement,” said S. Parikh Mars, CEO of Progressive Care. “We believe that our customizable transitional care solution DischargeRx will help to reduce readmission risk and improve health outcomes by eliminating gaps and impediments to adherence and access to care.”

Located in Miami, Fla., Westchester General Hospital is a leading hospital specializing in the provision of acute care and healthcare services to long-term care patients and the Miami-Dade community. For more than 50 years, Westchester has taken a hands-on approach to patient interaction and healthcare delivery. Its diverse and experienced staff and extensive hospital network provides a wide range of access to specialists, diagnostics, and therapies to encompass the full cycle of care for the patient.

For more information about Progressive Care, please visit the company’s website.

Connect and stay in touch with us on social media:

Progressive Care Inc.
https://www.facebook.com/ProgressiveCareUS/
https://twitter.com/ProgressCareUS

PharmCo, LLC
https://www.facebook.com/pharmcorx/
https://twitter.com/PharmCoRx

About Progressive Care Inc.
Progressive Care Inc. (OTCQB:RXMD), through its PharmCo, LLC, is a South Florida health services organization and provider of prescription pharmaceuticals, compounded medications, provider of tele-pharmacy services, the sale of anti-retroviral medications, medication therapy management (MTM), the supply of prescription medications to long term care facilities, and health practice risk management.

About Westchester General Hospital
Westchester General Hospital is a modern, acute care facility with a total of 197 beds, centrally located in the very heart of Miami, Florida. Westchester prides itself on a personal approach to patient care. Our staff of over 520 dedicated employees understand the importance of a caring, compassionate, and supportive environment while delivering exceptional care to our patients. Westchester General Hospital offers a broad range of services that include: Intensive Care, Emergency Services, Surgery, Orthopedics, G.I. Station, Urology, Gynecology, Plastic Surgery, Vascular, Podiatry, around the clock Diagnostic Ancillary Services, and more.

Cautionary Statement Regarding Forward Looking Statements
Statements contained herein that are not based upon current or historical fact are forward-looking in nature and constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Such forward-looking statements reflect the Company’s expectations about its future operating results, performance and opportunities that involve substantial risks and uncertainties. These statements include but are not limited to statements regarding the intended terms of the offering, closing of the offering and use of any proceeds from the offering. When used herein, the words “anticipate,” “believe,” “estimate,” “upcoming,” “plan,” “target,” “intend” and “expect” and similar expressions, as they relate to Progressive Care Inc., its subsidiaries, or its management, are intended to identify such forward-looking statements. These forward-looking statements are based on information currently available to the Company and are subject to a number of risks, uncertainties, and other factors that could cause the Company’s actual results, performance, prospects, and opportunities to differ materially from those expressed in, or implied by, these forward-looking statements.

Public Relations Contact:
Tory Patterson, CMW Media
Tory@cmwmedia.com
www.cmwmedia.com

Investor Relations Contact:
Armen Karapetyan, Progressive Care
Senior Advisor Business Development
Armen@progressivecareus.com
www.progressivecareus.com
www.pharmcopharmacy.com

Posted in Client News| Tagged |